← FDA Drug Approvals (Drugs@FDA)

DECITABINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2021-11-19

Drug application

FDA Application #
ANDA214486
Application type
Abbreviated New Drug Application (Generic)
Brand name
DECITABINE
Generic name
Decitabine
Active ingredients
DECITABINE
Dosage form
INJECTABLE
Route
INTRAVENOUS
Marketing status
Prescription
Sponsor
ZYDUS PHARMS
First approval
2021-11-19

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown